Amplimexon

· AmpliMed Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Amplimexon, covering 2010-11-30 to 2015-06-24. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer [Phase 2]